Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors [Phase 1]
A Phase 1 clinical trial evaluates chemotherapy plus peripheral stem cell transplantation in infants with malignant brain or spinal cord tum…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment [Phase 2]
Phase 2 trial of ABT-751 in children with relapsed or refractory neuroblastoma has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma [Phase 2]
This document provides an update on a Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for childr…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma [Phase 1]
This Phase 1 trial evaluated induction chemotherapy with cyclophosphamide and topotecan prior to autologous stem cell transplantation in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma [Phase 2]
A Phase 2 trial of the hu14.18-Interleukin-2 fusion protein in young patients with recurrent or refractory neuroblastoma has completed enrol…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma [Phase 2]
Phase 2 trial by the Children's Oncology Group evaluated irinotecan and temozolomide in young patients with recurrent neuroblastoma; results…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood stem cell transplantation for treating malignant and nonmalignant diseases in young p…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma [Phase 3]
A Phase 3 trial evaluating stage-based, risk-adapted therapy for children with neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma [Phase 2]
A Phase 2 trial comparing combination chemotherapy to observation after surgery in infants with Neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating a cancer vaccine therapy in combination with Interleukin-2 for relapsed or refractory Ewing sarcoma or Neu…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: R(+)XK469 in Treating Patients With Advanced Neuroblastoma [Phase 1]
A Phase 1 trial of R(+)-XK469 in patients with advanced neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma [Phase 3]
This is an update on a Phase 3 clinical trial evaluating combination chemotherapy before surgery for localized neuroblastoma in children.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma [Phase 2]
A Phase 2 clinical trial update evaluates the combination of monoclonal antibody therapy with etoposide for neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma [Phase 1]
Phase 1 clinical trial update evaluating the combination of the monoclonal antibody 3F8 and GM-CSF (sargramostim) in young patients with hig…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma [Phase 2]
A Phase 2 clinical trial evaluating fenretinide in children with recurrent or resistant neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating a combination of decitabine, doxorubicin, and cyclophosphamide in children with relapsed or refractory sol…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only [Phase 2]
A Phase 2 observational trial updates outcomes for young patients with localized neuroblastoma who were treated with surgery only.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma [Phase 1, Phase 2]
An update on a National Cancer Institute–sponsored Phase 1/Phase 2 trial evaluating a therapy for Ewing sarcoma, rhabdomyosarcoma, and neuro…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer [NA]
This clinical trial update concerns a pediatric cancer study evaluating Polyvinylpyrrolidone-Sodium Hyaluronate Gel to reduce pain from oral…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma [Phase 2]
A Phase 2 study evaluating initial combination chemotherapy followed by surgery and peripheral stem cell or bone marrow transplantation in i…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating combination chemotherapy for infants with newly diagnosed neurob…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. [Phase 2]
Phase 2 trial evaluating combination chemotherapy followed by surgery in infants with newly diagnosed neuroblastoma. The study has completed…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma [Phase 2]
Phase 2 clinical trial evaluating temozolomide in young patients with high-risk relapsed or refractory neuroblastoma has completed.